Caffeic Acid-PLGA Conjugate to Design Protein Drug Delivery Systems Stable to Irradiation
Source abstract
Abstract
This work reports the feasibility of caffeic acid grafted PLGA (g-CA-PLGA) to design biodegradable sterile microspheres for the delivery of proteins. Ovalbumin (OVA) was selected as model compound because of its sensitiveness of γ-radiation. The adopted grafting procedure allowed us to obtain a material with good free radical scavenging properties, without a significant modification of Mw and Tg of the starting PLGA (Mw PLGA = 26.3 ± 1.3 kDa vs. Mw g-CA-PLGA = 22.8 ± 0.7 kDa; Tg PLGA = 47.7 ± 0.8 °C vs. Tg g-CA-PLGA = 47.4 ± 0.2 °C). By using a W1/O/W2 technique, g-CA-PLGA improved the encapsulation efficiency (EE), suggesting that the presence of caffeic residues improved the compatibility between components (EEPLGA = 35.0% ± 0.7% vs. EEg-CA-PLGA = 95.6% ± 2.7%). Microspheres particle size distribution ranged from 15 to 50 µm. The zeta-potential values of placebo and loaded microspheres were −25 mV and −15 mV, respectively. The irradiation of g-CA-PLGA at the dose of 25 kGy caused a less than 1% variation of Mw and the degradation patterns of the non-irradiated and irradiated microspheres were superimposable. The OVA content in g-CA-PLGA microspheres decreased to a lower extent with respect to PLGA microspheres. These results suggest that g-CA-PLGA is a promising biodegradable material to microencapsulate biological drugs.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Advanced Drug Delivery Systems · Nanoparticle-Based Drug Delivery · Protein purification and stability
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Università degli Studi di Milano, Department of Pharmaceutical Sciences—via Giuseppe Colombo, 71-20133 Milano, Italy
Università degli Studi della Calabria, Department of Pharmacy, Health and Nutritional Sciences, 87036 Arcavacata di Rende, Italy
References (23)
Show source-provided references
1. Gamma irradiation effects on molecular weight and in vitro degradation of poly(lactide-co-glycolide) microparticles10.1023/A:1016256903322 ↗
2. Gamma irradiation effects on poly(d,l-lactide-co-glycolide) microspheres10.1016/S0168-3659(98)00082-0 ↗
3. Gamma irradiation effects on stability of poly(lactide-co-glycolide) microspheres containing clonazepam10.1016/S0168-3659(01)00401-1 ↗
4. Radiation-induced free radical reactions in polymer/drug systems for controlled release: An EPR investigation10.1016/S0969-806X(02)00404-8 ↗
5. Gamma irradiation effects and EPR investigation on poly(lactide-co-glycolide) microspheres containing bupivacaine10.1016/S0014-827X(02)01220-X ↗
6. Gamma irradiation for terminal sterilization of 17β-estradiol loaded poly(d,l-lactide-co-glycolide) microparticles10.1016/S0168-3659(99)00118-2 ↗
7. The effect of γ-irradiation on PLGA/PEG microspheres containing ovalbumin10.1016/j.jconrel.2005.05.029 ↗
8. Poly(lactide-co-glycolide) microspheres containing bupivacaine: Comparison between gamma and beta irradiation effects10.1016/S0168-3659(03)00153-6 ↗
9. Radiosterilisation of indomethacin PLGA/PEG-derivative microspheres: Protective effects of low temperature during gamma-irradiation10.1016/j.ijpharm.2006.01.034 ↗
10. A two-stage strategy for sterilization of poly(lactide-co-glycolide) particles by gamma-irradiation does not impair their potency for vaccine delivery10.1002/jps.22306 ↗
11. Design of methylprednisolone biodegradable microspheres intended for intra-articular administration10.1208/s12249-008-9158-1 ↗
12. Pyrogallic acid-PLGA conjugate as new biodegradable material suitable for final sterilization by irradiation10.1002/pat.1746 ↗
13. Encapsulation of antigen in poly(d,l-lactide-co-glycolde) microspheres protects from harmful effects of γ-irradiation as assessed in mice10.1016/j.ejpb.2011.10.007 ↗
14. Morphological characterization of microspheres, films and implants prepared from poly(lactide-co-glycolide) and ABA triblock copolymers: Is the erosion controlled by degradation, swelling or diffusion?10.1016/S0939-6411(01)00130-8 ↗
15. Lieberman, H.A., Rieger, M.M., and Banker, G.S. (1996). Pharmaceutical Dosage Forms—Disperse Systems, Marcel Dekker.
16. Injectability: An open issue10.1208/s12249-011-9625-y ↗
17. Methylprednisolone-loaded PLGA microspheres: A new formulation for sustained release via intra-articular administration. A comparison study with methylprednisolone acetate in rats10.1002/jps.22722 ↗
18. The mechanisms of drug release in poly(lactic-co-glycolic acid)-based drug delivery systems—A review10.1016/j.ijpharm.2011.05.049 ↗
19. Conti, B., Groppo, A., Genta, I., Dacarro, C., Valvo, L., Cilurzo, F., and Montanari, L. (2000, January 7–13). Comparison among different preparation methods of ovalbumin loaded PLGA microspheres. Proceedings of 27th International Symposium on Controlled Release of Bioactive Materials, Paris, France.
20. (1991). The Use of Ionizing Radiation in the Manufacture of Medicinal Products, European Medicines Agency. European Guideline 3AQ4a.
21. Radiation-induced protein fragmentation and inactivation in liquid and solid aqueous solutions. Role of OH and electrons10.1016/j.radphyschem.2003.12.060 ↗
22. Radiolysis of proteins in the solid state: An approach by EPR and product analysis10.1107/S0909049505003304 ↗
23. Accelerated polymer biodegradation of risperidone poly(d,l-lactide-co-glycolide) microspheres10.1208/s12249-012-9874-4 ↗